Estonian Government Plans to Expand Smoke-Free Areas

Jun.27.2024
Estonian Government Plans to Expand Smoke-Free Areas
Estonian government plans to expand smoke-free zones in public areas like beaches and parks, aiming to restrict tobacco use.

According to ERR News, the Estonian government plans to expand smoke-free areas, aiming to limit smoking in public places such as beaches and parks. This policy is intended to equally restrict all tobacco and nicotine products.


Last week, the Estonian government approved its position on European tobacco policy. This includes expanding smoke-free areas on terraces, in parks, on beaches, and in other crowded leisure areas. For example, designated smoking areas with signs and trash bins have been set up on beaches in Latvia and Lithuania.


Aive Telling, Head of Environmental Health and Chemical Safety at the Estonian Ministry of Social Affairs, explained the plan.


Today, we are talking about restrictions that still allow individuals to smoke, but in a way that does not harm the health of those around them. This is the most important point in ensuring a smoke-free environment. We must consider others, and this is also key in changing societal attitudes to ensure our actions do not harm others.


Director of the Tartu Health Department, Piret Väljaots, emphasized concerns about compliance with these restrictions.


For example, today, drinking behavior on the beach is being supervised, and people will be reminded that drinking on the beach is not allowed. Similarly, tobacco use may also be monitored during the beach season. However, for public places such as parks, the issue becomes more complicated because these places do not have ongoing legal supervision.


Currently, the Department of Social Affairs does not have a detailed implementation plan yet.


Wei Ling said,


The situation will not change overnight, this is just the beginning of a long-term and broader process. Today, these positions represent the direction we are progressing in Europe.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
A new study shows that flavored e-cigarettes, even without nicotine, can interfere with embryo implantation and placental development, increasing the risks of miscarriage and fetal growth restriction, underscoring their potential threat to pregnancy safety.
Sep.01 by 2FIRSTS.ai
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
The U.S. Bankruptcy Court in New York has approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., granting legal effect in the U.S. to its participation in a CA$32.5 billion (US$23.6 billion) tobacco litigation settlement. The case is considered one of the largest corporate restructurings in Canadian history and also involves Japan Tobacco International (JTI), Philip Morris International (PMI), and British American Tobacco (BAT).
Aug.28 by 2FIRSTS.ai
FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance
FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance
FDA Commissioner Robert Califf urged the DEA to classify 7-OH, an opioid-like compound found in vapes, drinks, and gummies, as a Schedule I substance. The FDA plans national warnings for doctors and tighter control of high concentrations.
Jul.30 by 2FIRSTS.ai
Philip Morris Korea Launches "Classic Dark Green" Heatsticks Exclusively for IQOS ILUMA; SENTIA Series Expands to 5 Flavors
Philip Morris Korea Launches "Classic Dark Green" Heatsticks Exclusively for IQOS ILUMA; SENTIA Series Expands to 5 Flavors
Philip Morris International Korea Unveils "Classic Dark Green," a New Exclusive for IQOS ILUMA, Growing SENTIA Series to 5 Products.
Aug.26 by 2FIRSTS.ai
UK MHRA Releases Database with 329 e-cigarette SKUs, Including Brands like ELFBAR, SKE, OXVA, and INNOKIN
UK MHRA Releases Database with 329 e-cigarette SKUs, Including Brands like ELFBAR, SKE, OXVA, and INNOKIN
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK announced 329 SKUs in its e-cigarette product notification database between August 2 and August 10, including updates on rechargeable e-cigarettes, open-system e-cigarettes, and multi-flavor pods from brands such as ELFBAR, OXVA, INNOKIN, SKE, and VAPES BARS.
Aug.11 by 2FIRSTS.ai
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
2Firsts interviewed Imperial Brands on FDA’s blu denial. ITG Brands responded with disappointment, vowing to pursue a fair, science-based review.
Aug.22